USPTO 2015–2025 USPTO PatentsView US Corporation

Electrocore, Inc.

USPTO PatentsView assignee record - 128 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Electrocore ranks #2,961 of 49,997 tracked US assignees by granted-patent volume, with 128 patents across 14 technology areas.

#2,961
of 49,997 US assignees by volume
Top 12%
by Innovation Score (51.0/100)
22.7
avg claims per patent
-18%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2961 · US Corporation #2,961 · 128 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MID 128 grants
  • TOP-DECILE #2,961/49,997
  • PHOTO-FINISH Beijing Kuaimajiabia…
  • CPC-FOCUS A61N · 14 areas
  • INNOV-PAR 51.0/100
  • CLAIMS-DENSE 22.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -18% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Beijing Kuaimajiabian Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Electrocore

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Electrocore's Innovation Score is 51.0/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Electrocore's grants concentrate

Electrocore, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 97.7% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2019 (25 grants) versus a trough of 1 in 2018. By volume, Electrocore sits between Beijing Kuaimajiabian Technology Co., Ltd. and Home BOX Office, Inc..

Electrocore's three-year grant acceleration

From 2019–2021 to 2022–2024, Electrocore, Inc. moved from 38 to 42 grants (1.10x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #947. See the growth leaderboard.

Who files at Electrocore's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Electrocore holds 128 patents at rank #2,962, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Electrocore

By rank, the assignees closest to #2,962 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Electrocore's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Electrocore, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (51 here).

Similar claim depth

Nearest assignees by average claims per patent (22.7 here).

Electrocore's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0102030 20152016201720182019202020212022202320242025 6
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Electrocore, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 18 14.1%
2016 17 13.3%
2017 6 4.7%
2018 1 0.8%
2019 25 19.5%
2020 3 2.3%
2021 10 7.8%
2022 18 14.1%
2023 14 10.9%
2024 10 7.8%
2025partial year 6 4.7%

Which technologies does Electrocore, Inc. patent most?

Top 14 of 14 technology areas

Where it ranks

Overall rank by patents

#2,961

of 49,997 tracked assignees

Innovation Score

51.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Electrocore, Inc.'s patent record in context - here's where to go next.

  • Electrocore, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 97.7% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #2,961 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Electrocore, Inc. against Beijing Kuaimajiabian Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 51.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.